RxDoctor Payments Data

Jeffrey Friedman, MD

Plastic and Reconstructive Surgery · Houston, TXNPI 1942235114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 26.2% of the total. Reporting peaked in 2023 at $579 and has fallen 81.3% since, to $108 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in TX, where the typical reported total is $2,813.

$2,791in general payments, 2019–2025

Across 61 payments — averaging $45.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$731
  • Sientra, Inc.$328
  • Johnson & Johnson$266
  • Davol Inc.$202
  • Mentor Worldwide LLC$177
  • Medtronic$172
  • plus $915 from 14 others
$156,649in research payments, 2019–2025

Across 201 payments — averaging $779.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$151K
  • Medical Device Business Services, Inc.$6K

What the payments were for

  • Travel & lodging$130%
  • Food & beverage$2,778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,791 in reported general payments places this provider in the 45th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas

Medicare billing

Part B allowed, 2024
$29,053
Medicare patients
52
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Minocycline Hcl46$598
Ondansetron Hcl25$166

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →